SYDNEY CARNAHAN: Open Payments
NPI 1801543871 · SAINT JOSEPH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,225 in 60 payments from 14 companies in 2025. Trend: 2023 $1,923 · 2024 $1,137 · 2025 $1,225
Food & beverage: $1,225
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $280 |
| GENZYME CORPORATION | 8 | $171 |
| Regeneron Healthcare Solutions, Inc. | 5 | $140 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $127 |
| UCB, Inc. | 6 | $123 |
| Novartis Pharmaceuticals Corporation | 5 | $108 |
| Amgen Inc. | 4 | $68 |
| Incyte Corporation | 3 | $53 |
| ABBVIE INC. | 2 | $39 |
| E.R. Squibb & Sons, L.L.C. | 1 | $33 |
Products named: TREMFYA, DUPIXENT, Bimzelx, COSENTYX, OTEZLA, BLU-U, OPZELURA, SKYRIZI.
Industry payments across MO — which companies pay providers there.
